Management of patients diagnosed with PID
| STI identified (n=58) | No STI identified (n=72) | |
| Partner notification (PN) | ||
| Partner notified | 21 (36.2%) | 19 (26.4%) |
| Partner notified and treated | 20 (34.5%) | 5 (6.9%) |
| PN recommended | 6 (10.3%) | 0 |
| No documentation of PN | 31 (53.5%) | 53 (73.6%) |
| Treatment prescribed | ||
| Doxycycline and metronidazole | 46 (79.3%) | 59 (81.9%) |
| Macrolide and metronidazole | 6 (10.4%) | 7 (9.7%) |
| Ofloxacin and metronidazole (GC cover) | 5 (8.6%) | 5 (7.0%) |
| Cephalosporin prescribed (GC cover) | 40 (69.0%) | 44 (61.1%) |
| Follow-up | ||
| Follow-up advised in 3 days | 0 | 0 |
| Follow-up advised in 2–4 weeks | 47 (81%) | 69 (95.8%) |
| Follow-up attended | 47 (81%) | 29 (40.3%) |